ACE2 and viral infectious disease: Knockdown of OCLN in SARS-CoV-2permissive Vero-E6 and A549-hACE2 cells does not impact ACE2 expression (SI Appendix, Fig. S1 B and C) but significantly reduces virus infection, especially during the internalization stage and subsequent viral replication.